Egypt-based healthtech startup Chefaa has secured an undisclosed amount in its pre-Series A funding round led by 500 Startups, Vision Ventures, Womena, and a few other investors, the media reported.
According to Chefaa, it will use the funding to grow its operations team and launch its B2B service to serve small and medium-sized enterprises (SME).
Chefaa is on an on-demand medical delivery platform that its customers with their local pharmacies, enabling chronic patients in Egypt to schedule, order, and refill their recurring prescriptions as well as other non-pharmaceutical products through its web or mobile application.
Dr. Rasha Rady, the co-founder, and COO of the startup told the media, ”We take pride in serving our growing base of users as well as managing their pharmacy needs. We have built our customer care center to ensure that user experience is being managed professionally. We also understand the impact of chronic illness as well as chronic patients’ needs and we intend to launch new services all designed around making their lives easier.”
Established in 2017 by Doaa Aref and Dr. Rasha Rady, Chefaa claims it is helping tens of thousands of chronic patients across Egypt to properly manage their treatment by enabling them to easily order their medicines online.
Last year, the startup announced that it has raised seed funding in a round led by 500 Startups with the participation of Flat6Labs and a group of undisclosed angel investors.
Chefaa, which is based in Cairo, operates in nine Egyptian cities and has generated sales of over $1 million as of 2019, completing more than 100,000 orders through its network of 800+ pharmacies.